Nasdaq: KROS
Keros Therapeutics insiders
The officers, directors and 10% owners of Keros Therapeutics, Inc. who hold the most stock, valued at the live KROS price.
$11.39
KROS today −$610K (−5.08%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their KROS stock
- $5.7M
- Market value
- $224M
- Held by ranked insiders
- 2.57%
Insiders by value of KROS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Jasbir Seehra | CHIEF EXECUTIVE OFFICER | 440,708 | $5.0M | 2.25% | 14416th |
| 2 | Yung H. Chyung | Chief Medical Officer | 44,000 | $501K | 0.22% | 6990th |
| 3 | Jean Jacques Bienaime | Director | 19,592 | $223K | <0.1% | 2620th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Keros Therapeutics; see each profile for the filing.